Suppr超能文献

可乐定、普萘洛尔与安慰剂治疗中度高血压的比较试验。

A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.

作者信息

Wilkinson P R, Raftery E B

出版信息

Br J Clin Pharmacol. 1977 Jun;4(3):289-94. doi: 10.1111/j.1365-2125.1977.tb00714.x.

Abstract

1 A double-blind cross over trial between clonidine, propranolol and a placebo in patients with moderate hypertension has been performed. 2 Thirty-two patients completed the study which consisted of three treatment periods in random order of 3 months each. Patients had their blood pressure recorded by an unbiased observer using a random-zero machine. 3 Both clonidine and propranolol produced a significant reduction in blood pressure (P less than 0.01), which was apparent by the second week of therapy. Propranolol gave a greater reduction in pulse rate than clonidine (P less than 0.01) but clonidine also reduced the pulse rate significantly (P less than 0.05). There was no evidence of postural hypotension on either drug. Side-effects were more common with clonidine but these tended to wear off after several weeks of therapy. 4 Clonidine and propranolol were equipotent in reducing blood pressure, but clonidine has more initial side-effects than propranolol.

摘要
  1. 已对中度高血压患者进行了可乐定、普萘洛尔与安慰剂的双盲交叉试验。2. 32名患者完成了该研究,研究包括三个治疗期,每个治疗期为3个月,治疗顺序随机。患者的血压由一名无偏见的观察者使用随机零点血压计记录。3. 可乐定和普萘洛尔均使血压显著降低(P<0.01),在治疗的第二周就很明显。普萘洛尔使心率降低的幅度大于可乐定(P<0.01),但可乐定也使心率显著降低(P<0.05)。两种药物均未出现体位性低血压的证据。可乐定的副作用更常见,但在治疗几周后这些副作用往往会逐渐消失。4. 可乐定和普萘洛尔在降低血压方面效果相当,但可乐定比普萘洛尔有更多的初始副作用。

相似文献

1
可乐定、普萘洛尔与安慰剂治疗中度高血压的比较试验。
Br J Clin Pharmacol. 1977 Jun;4(3):289-94. doi: 10.1111/j.1365-2125.1977.tb00714.x.
2
Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
J Clin Pharmacol. 1989 Jan;29(1):18-24. doi: 10.1002/j.1552-4604.1989.tb03232.x.
4
Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.
Acta Neurol Scand. 1980 Jun;61(6):351-6. doi: 10.1111/j.1600-0404.1980.tb01504.x.
5
Use of clonidine and propranolol as monotherapy in borderline hypertension.
Chest. 1983 Feb;83(2 Suppl):422-5. doi: 10.1378/chest.83.2_supplement.422.
6
普萘洛尔治疗高血压的对照试验。
Br Med J. 1970 Feb 21;1(5694):471-4. doi: 10.1136/bmj.1.5694.471.
7
8
依那普利治疗原发性高血压:与普萘洛尔的对比研究。依那普利高血压研究组(英国)
Br J Clin Pharmacol. 1984 Jul;18(1):51-6. doi: 10.1111/j.1365-2125.1984.tb05021.x.
9
氧烯洛尔与普萘洛尔治疗原发性高血压效果的比较研究
J Clin Pharmacol. 1979 Jan;19(1):8-14. doi: 10.1002/j.1552-4604.1979.tb01611.x.
10
拉贝洛尔(柳胺苄心定)、普萘洛尔与安慰剂治疗轻至中度高血压的对照试验
Br J Clin Pharmacol. 1979 Jan;7(1):63-8. doi: 10.1111/j.1365-2125.1979.tb00898.x.

引用本文的文献

本文引用的文献

1
新型抗高血压药物2-(2,6-二氯苯胺)-2-咪唑啉盐酸盐的临床观察
Am Heart J. 1969 Apr;77(4):473-8. doi: 10.1016/0002-8703(69)90156-2.
2
可乐定治疗高血压
Br Med J. 1970 Aug 22;3(5720):440-2. doi: 10.1136/bmj.3.5720.440.
3
可乐定治疗良性高血压。
Scott Med J. 1970 Apr;15(4):137-42. doi: 10.1177/003693307001500403.
4
The use of "Catapres" in the treatment of severe hypertension.
Med J Aust. 1969 Oct 4;2(14):684-7. doi: 10.5694/j.1326-5377.1969.tb107345.x.
6
普萘洛尔治疗高血压:1964 - 1970年长期治疗研究
Am Heart J. 1972 Jun;83(6):755-61. doi: 10.1016/0002-8703(72)90206-2.
7
一种咪唑啉化合物的降压作用。
Clin Pharmacol Ther. 1967 Nov-Dec;8(6):810-6. doi: 10.1002/cpt196786810.
8
家兔中枢去甲肾上腺素能神经元及可乐定的心血管作用
Br J Pharmacol. 1973 Feb;47(2):206-16. doi: 10.1111/j.1476-5381.1973.tb08318.x.
10
A possible pharmacological approach to migraine.
Lancet. 1969 Aug 9;2(7615):298-300. doi: 10.1016/s0140-6736(69)90058-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验